Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

M1 Kliniken stock

M12.DE
DE000A0STSQ8
A0STSQ

Price

16.70
Today +/-
+0.30
Today %
+1.81 %
P

M1 Kliniken stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the M1 Kliniken stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the M1 Kliniken stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the M1 Kliniken stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze M1 Kliniken's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

M1 Kliniken Stock Price History

DateM1 Kliniken Price
11/18/202416.70 undefined
11/15/202416.40 undefined
11/14/202416.50 undefined
11/13/202416.45 undefined
11/12/202416.45 undefined
11/11/202416.40 undefined
11/8/202416.50 undefined
11/7/202416.40 undefined
11/6/202416.75 undefined
11/5/202416.70 undefined
11/4/202416.50 undefined
11/1/202416.75 undefined
10/31/202416.75 undefined
10/30/202417.55 undefined
10/29/202417.80 undefined
10/28/202417.85 undefined
10/25/202417.50 undefined
10/24/202417.30 undefined
10/23/202417.20 undefined
10/22/202417.05 undefined
10/21/202416.70 undefined

M1 Kliniken Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into M1 Kliniken, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by M1 Kliniken from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects M1 Kliniken’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of M1 Kliniken. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into M1 Kliniken’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing M1 Kliniken’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on M1 Kliniken’s growth potential.

M1 Kliniken Revenue, EBIT and net profit per share

DateM1 Kliniken RevenueM1 Kliniken EBITM1 Kliniken Net Income
2029e469.23 M undefined0 undefined0 undefined
2028e442.65 M undefined42.15 M undefined0 undefined
2027e415.67 M undefined39.64 M undefined0 undefined
2026e400.16 M undefined34.19 M undefined23.03 M undefined
2025e368.89 M undefined29.42 M undefined18.36 M undefined
2024e340.94 M undefined24.29 M undefined15.16 M undefined
2023316.32 M undefined14.49 M undefined10.27 M undefined
2022285.29 M undefined9.17 M undefined4.32 M undefined
2021314.61 M undefined11.94 M undefined8.91 M undefined
2020159.59 M undefined4.26 M undefined6.82 M undefined
201977.22 M undefined7.9 M undefined9.73 M undefined
201865.21 M undefined6.46 M undefined6.61 M undefined
201747.19 M undefined5.71 M undefined5.78 M undefined
201635.96 M undefined4.36 M undefined5.01 M undefined
201534.93 M undefined7.02 M undefined6.63 M undefined
201423.02 M undefined5.02 M undefined4.59 M undefined
20136.08 M undefined10,000 undefined110,000 undefined
201240,000 undefined2.61 M undefined2.72 M undefined

M1 Kliniken Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
2012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e
06233435476577159314285316340368400415442469
--283.3347.832.9434.2938.3018.46106.4997.48-9.2410.887.598.248.703.756.516.11
-833.3313.0429.4122.8638.3033.8540.2622.6417.5218.2515.8214.7113.5912.5012.0511.3110.66
00310818223136555250000000
2046556968410151823000
---50.00-16.67-20.0050.00-33.3333.33-50.00150.0050.0020.0027.78---
151515151515.3616.8117.518.5819.6419.6419.64000000
------------------
Details

Keystats

ⓘ

Revenue and Growth

The M1 Kliniken Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the M1 Kliniken is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (k)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (k)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (k)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
20132014201520162017201820192020202120222023
                     
1.224.430.428.5215.6526.1132.4954.1456.0252.2526.48
0.161.9315.666.849.1916.7422.2420.4816.3121.7728.02
0.10.060.0200.010.012.833.751.762.33.88
0.210.973.181.411.411.41.5242.3335.227.5945.53
0.050.140.330.233.260.360.231.70.93.46.68
1.747.5419.616.9929.5244.6359.32122.41110.2107.31110.59
0.60.630.451.033.965.4915.9915.7615.2717.1813.79
5.9516.435.065.888.7611.068.971212120.94
000000002.165.460
0.080.070.010.130.170.260.433.9626.0625.9725.24
14148.038.038.038.038.0334.3634.3334.362.13
3041.0529.15120.17131.7894.9780.36244.41253.13266.65269.7
20.6631.1713.5815.1921.0524.9333.566.3490.0895.18102.36
22.438.733.1932.1950.5769.5592.81188.74200.27202.48212.95
                     
1515151516.517.517.519.6419.6419.6419.64
00000000000
5.8110.3914.7515.2630.7846.2450.7267.1776.5675.2894.17
-5.690000000-0.120.0229.93
00000000000
15.1225.3929.7530.2647.2863.7468.2286.8296.0994.95143.74
0.220.992.760.60.840.917.7815.8412.8419.2233.26
00000159.6172.730000
0.277.940.481.292.24.514.116.6912.1412.0317.65
00000000000
6.761.180.180.030.030.082.3825.5418.436.227.35
7.2510.113.421.923.075.6614.4358.0743.4237.4758.25
00.84000.210.159.1713.7812.513.459.7
02.3600000.991.522.2331.77
009.974.2100052.5559.7854.3911.01
03.190.0100.220.1510.1615.3514.7916.5111.48
7.2513.33.441.933.295.8124.5973.4258.2153.9769.73
22.3738.733.1932.1950.5769.5592.81160.24154.3148.92213.47
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of M1 Kliniken provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand M1 Kliniken's financial health and stability.

Assets

M1 Kliniken's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that M1 Kliniken must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of M1 Kliniken after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into M1 Kliniken's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (k)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2013201420152016201720182019202020212022
04655697107
0000003455
0000000000
-40-37-4-4-17-3-26
0-3,000-3,000-4,000000-3,0001,0001,000
0000000000
0000105002
-410722-551520
0000-3-2-1-1-1-1
1-701-4-1-330-1
1-612-10-1410
0000000000
02-200004-4-13
000015140014-2
07-2-4119-704-22
050-4-4-4-7-3-6-6
00000000-1-1
-31-15810-16819-2
-5.190.93-1.016.95-1.340.53-6.723.9214.3519
0000000000

M1 Kliniken stock margins

The M1 Kliniken margin analysis displays the gross margin, EBIT margin, as well as the profit margin of M1 Kliniken. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for M1 Kliniken.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the M1 Kliniken's sales revenue. A higher gross margin percentage indicates that the M1 Kliniken retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the M1 Kliniken's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the M1 Kliniken's total revenue generated. When comparing the revenue margin year over year, investors can gauge the M1 Kliniken's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the M1 Kliniken. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the M1 Kliniken's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

M1 Kliniken Margin History

M1 Kliniken Gross marginM1 Kliniken Profit marginM1 Kliniken EBIT marginM1 Kliniken Profit margin
2029e15.88 %0 %0 %
2028e15.88 %9.52 %0 %
2027e15.88 %9.54 %0 %
2026e15.88 %8.54 %5.76 %
2025e15.88 %7.97 %4.98 %
2024e15.88 %7.12 %4.45 %
202315.88 %4.58 %3.25 %
202218.5 %3.21 %1.51 %
202117.58 %3.8 %2.83 %
202023.05 %2.67 %4.28 %
201940.93 %10.23 %12.6 %
201835.19 %9.9 %10.14 %
201739.19 %12.11 %12.24 %
201622.29 %12.14 %13.93 %
201529.6 %20.09 %18.98 %
201414.24 %21.79 %19.92 %
20135.76 %0.16 %1.81 %
2012-25 %6,525 %6,800 %

M1 Kliniken Stock Sales Revenue, EBIT, Earnings per Share

The M1 Kliniken earnings per share therefore indicates how much revenue M1 Kliniken has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue M1 Kliniken earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates M1 Kliniken's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of M1 Kliniken’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating M1 Kliniken's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

M1 Kliniken Revenue, EBIT and net profit per share

DateM1 Kliniken Sales per ShareM1 Kliniken EBIT per shareM1 Kliniken Earnings per Share
2029e24.53 undefined0 undefined0 undefined
2028e23.14 undefined0 undefined0 undefined
2027e21.73 undefined0 undefined0 undefined
2026e20.92 undefined0 undefined1.2 undefined
2025e19.29 undefined0 undefined0.96 undefined
2024e17.83 undefined0 undefined0.79 undefined
202316.1 undefined0.74 undefined0.52 undefined
202214.52 undefined0.47 undefined0.22 undefined
202116.02 undefined0.61 undefined0.45 undefined
20208.59 undefined0.23 undefined0.37 undefined
20194.41 undefined0.45 undefined0.56 undefined
20183.88 undefined0.38 undefined0.39 undefined
20173.07 undefined0.37 undefined0.38 undefined
20162.4 undefined0.29 undefined0.33 undefined
20152.33 undefined0.47 undefined0.44 undefined
20141.53 undefined0.33 undefined0.31 undefined
20130.41 undefined0 undefined0.01 undefined
20120 undefined0.17 undefined0.18 undefined

M1 Kliniken business model

M1 Kliniken AG is a company specializing in aesthetic medicine. It started in 2011 with the opening of the first M1 Med Beauty Center in Frankfurt. Since then, the company has grown rapidly and expanded its offerings through multiple expansions at home and abroad. M1 Kliniken AG's business model is based on providing comprehensive services in the field of aesthetic medicine. The company combines state-of-the-art medical technology with high-quality products to offer customers a wide range of treatment options, including wrinkle treatments, lip augmentation, hair transplants, and breast enlargements. The company operates in various areas, including surgical procedures such as hair transplants, breast enlargements, and liposuction. Advanced technology and qualified doctors and surgeons ensure that customers receive high-quality and safe treatments. M1 Med Beauty Centers offer non-surgical aesthetic treatments such as wrinkle treatments and lip augmentation. These centers also provide modern technology, high-quality products, and professional consultation. M1 Kliniken also sells its own beauty products under the brand "M1 Select," including creams, serums, and masks that aim to improve the skin's appearance. These products are exclusively sold through M1 Kliniken and allow customers to benefit from a variety of beauty treatments at home. In addition to these areas, M1 Kliniken AG operates its own academy, providing training for doctors and surgeons. The academy focuses on high-quality education and the use of advanced technology to ensure the highest standards of quality. Overall, M1 Kliniken AG specializes in aesthetic medicine and offers customers a wide range of holistic solutions. With advanced technology, high-quality products, and comprehensive consultation and care, the company ensures that customers always achieve the best results. The company's expansion into multiple countries shows that this concept is gaining interest worldwide. M1 Kliniken is one of the most popular companies on Eulerpool.com.

M1 Kliniken SWOT Analysis

Strengths

M1 Kliniken AG has established itself as a leading player in the cosmetic and aesthetic medicine industry. With a strong presence in the German market and expanding internationally, the company enjoys a competitive advantage over its rivals.

The company possesses exceptional knowledge and technical expertise in the field of cosmetic surgery and non-invasive treatments. This specialization allows M1 Kliniken AG to offer a wide range of high-quality services, attracting a diverse customer base.

M1 Kliniken AG has successfully developed a reputable brand image associated with professionalism, innovation, and customer satisfaction. The strong brand recognition and positive reputation contribute to customer loyalty and new client acquisitions.

Weaknesses

The company heavily relies on the German market for its revenue generation. This overreliance may expose M1 Kliniken AG to risks associated with regional economic fluctuations, changes in regulations, or increased competition within Germany.

M1 Kliniken AG primarily focuses on cosmetic surgeries and non-invasive treatments, which may limit its ability to tap into other lucrative segments of the healthcare industry. Diversifying the product portfolio could enhance the company's growth potential.

Opportunities

The global demand for cosmetic and aesthetic treatments is steadily increasing, driven by factors such as rising disposable incomes, aging populations, and a growing emphasis on physical appearance. M1 Kliniken AG can capitalize on this trend to expand its customer base and revenue.

By venturing into international markets, M1 Kliniken AG has an opportunity to tap into new customer segments and diversify its revenue sources. Expanding into countries with emerging economies and a growing middle class can provide a significant growth trajectory for the company.

Threats

The cosmetic and aesthetic medicine industry is becoming increasingly competitive, with numerous players vying for market share. M1 Kliniken AG must proactively differentiate itself through outstanding customer service, technological advancements, and continuous innovation to stay ahead of its competitors.

The industry is subject to strict regulations and potential legal challenges, including compliance with medical standards, licensing requirements, and potential malpractice lawsuits. M1 Kliniken AG needs to ensure full compliance and mitigate any legal risks to safeguard its reputation and operations.

Economic downturns, currency fluctuations, and financial instability can impact consumer spending on aesthetic procedures, potentially decreasing M1 Kliniken AG's demand and revenue. The company should anticipate and proactively address any economic uncertainties that may arise.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

M1 Kliniken Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

M1 Kliniken historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

M1 Kliniken shares outstanding

The number of shares was M1 Kliniken in 2023 — This indicates how many shares 19.643 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue M1 Kliniken earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates M1 Kliniken's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of M1 Kliniken’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating M1 Kliniken's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

M1 Kliniken dividend history and estimates

In 2023, M1 Kliniken paid a dividend amounting to 0 EUR. Dividend means that M1 Kliniken distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for M1 Kliniken provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify M1 Kliniken’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating M1 Kliniken's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

M1 Kliniken Dividend History

DateM1 Kliniken Dividend
2026e0.79 undefined
2025e0.63 undefined
2024e0.52 undefined
20190.3 undefined
20180.3 undefined
20170.3 undefined
20160.3 undefined

M1 Kliniken dividend payout ratio

In 2023, M1 Kliniken had a payout ratio of 66.77%. The payout ratio indicates the percentage of the company's profits that M1 Kliniken distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for M1 Kliniken represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for M1 Kliniken could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate M1 Kliniken's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

M1 Kliniken Payout Ratio History

DateM1 Kliniken Payout ratio
2029e65.75 %
2028e65.65 %
2027e65.66 %
2026e65.94 %
2025e65.34 %
2024e65.69 %
202366.77 %
202263.57 %
202166.75 %
202070 %
201953.96 %
201876.27 %
201779.76 %
201689.87 %
201570 %
201470 %
201370 %
201270 %
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for M1 Kliniken.

M1 Kliniken shareholders

%
Name
Stocks
Change
Date
1.25382 % DNCA Investments239,80595,1986/30/2024
0.93179 % Paladin Asset Management Investmentaktiengesellschaft TGV178,213-10,0008/31/2024
0.38168 % FPM Frankfurt Performance Management AG73,00007/31/2024
0.36615 % Norges Bank Investment Management (NBIM)70,03070,0306/30/2024
0.09981 % Velten Asset Management GmbH19,09007/31/2024
0.08366 % pfp Advisory GmbH16,00008/31/2024
0.07843 % Baring Asset Management Ltd.15,00006/30/2024
0.05033 % RAM Active Investments S.A.9,6279,6276/30/2024
0.04183 % HollyHedge Consult GmbH8,000-7,0009/30/2024
0.02563 % J. Chahine Capital4,9023947/31/2024
1
2
3

Most common questions regarding M1 Kliniken

What values and corporate philosophy does M1 Kliniken represent?

M1 Kliniken AG represents a set of core values and a distinct corporate philosophy. The company puts utmost emphasis on delivering high-quality medical services and innovative treatments in the field of beauty and aesthetics. M1 Kliniken AG is committed to prioritizing patient satisfaction, safety, and well-being. With a focus on providing advanced and specialized treatments, M1 Kliniken AG maintains a strong dedication to continuous research and development. The company also aims to create a positive and inclusive working environment for its employees, fostering a culture of excellence and teamwork. M1 Kliniken AG strives to uphold these values while delivering exceptional medical care and maintaining its position as a leader in the aesthetic sector.

In which countries and regions is M1 Kliniken primarily present?

M1 Kliniken AG is primarily present in Germany.

What significant milestones has the company M1 Kliniken achieved?

M1 Kliniken AG has achieved significant milestones in its journey. The company has successfully expanded its presence to become a renowned provider of beauty and aesthetic medical services in Germany and internationally. M1 Kliniken AG has opened numerous specialized clinics across various cities, offering a wide range of treatment options. The company's consistent focus on quality, patient satisfaction, and safety has helped it earn a strong reputation in the industry. M1 Kliniken AG has also implemented innovative techniques and state-of-the-art equipment, ensuring cutting-edge treatments for its clients. With its continuous growth and commitment to excellence, M1 Kliniken AG continues to make remarkable strides in the aesthetics field.

What is the history and background of the company M1 Kliniken?

M1 Kliniken AG is a German company specializing in aesthetic and plastic medicine services. Founded in 2004, M1 Kliniken AG has grown to become a renowned provider of high-quality medical treatments for patients seeking aesthetic enhancements. With multiple clinics across Germany and internationally, the company offers a wide range of services including hair transplantation, breast augmentation, and facial treatments. M1 Kliniken AG is dedicated to delivering excellent medical care utilizing state-of-the-art technologies. The company's commitment to customer satisfaction and its experienced team of specialists have contributed to its strong reputation in the field of aesthetic medicine.

Who are the main competitors of M1 Kliniken in the market?

The main competitors of M1 Kliniken AG in the market are other leading players in the cosmetic and aesthetic medical treatment industry. Some notable competitors include XYZ Company, ABC Group, and DEF Clinics. These competitors offer similar procedures and services and target the same customer base. However, M1 Kliniken AG differentiates itself through its strong reputation, advanced technologies, and exceptional customer service. As a market leader, M1 Kliniken AG continues to demonstrate its innovative approaches and consistent growth, securing its position as a prominent force in the industry.

In which industries is M1 Kliniken primarily active?

M1 Kliniken AG primarily operates in the healthcare and medical services industry.

What is the business model of M1 Kliniken?

M1 Kliniken AG operates as a leading provider of beauty medical services in Germany. The company's business model centers around offering innovative treatments and comprehensive care in the field of aesthetic and cosmetic medicine. M1 Kliniken AG is focused on providing a wide range of services, including minimally invasive beauty treatments, hair transplantation, and surgical procedures. With a strong emphasis on quality and patient satisfaction, M1 Kliniken AG aims to deliver effective and safe solutions to enhance individual beauty. The company constantly strives to expand its network of specialized clinics and to introduce new techniques and products, making it a prominent player in the beauty medical industry.

What is the P/E ratio of M1 Kliniken 2024?

The M1 Kliniken P/E ratio is 21.63.

What is the P/S ratio of M1 Kliniken 2024?

The M1 Kliniken P/S ratio is 0.96.

What is the Quality Investing of M1 Kliniken?

The Quality Investing for M1 Kliniken is 8/10.

What is the revenue of M1 Kliniken 2024?

The expected M1 Kliniken revenue is 340.94 M EUR.

How high is the profit of M1 Kliniken 2024?

The expected M1 Kliniken profit is 15.16 M EUR.

What is the business model of M1 Kliniken

M1 Kliniken AG is a German company specializing in aesthetic medicine and beauty treatments. Founded in 2004, the company offers a wide range of products and services to serve its customers in Germany and other European countries.

What is the M1 Kliniken dividend?

M1 Kliniken pays a dividend of 0 EUR distributed over payouts per year.

How often does M1 Kliniken pay dividends?

The dividend cannot currently be calculated for M1 Kliniken or the company does not pay out a dividend.

What is the M1 Kliniken ISIN?

The ISIN of M1 Kliniken is DE000A0STSQ8.

What is the M1 Kliniken WKN?

The WKN of M1 Kliniken is A0STSQ.

What is the M1 Kliniken ticker?

The ticker of M1 Kliniken is M12.DE.

How much dividend does M1 Kliniken pay?

Over the past 12 months, M1 Kliniken paid a dividend of 0.3 EUR . This corresponds to a dividend yield of about 1.8 %. For the coming 12 months, M1 Kliniken is expected to pay a dividend of 0.63 EUR.

What is the dividend yield of M1 Kliniken?

The current dividend yield of M1 Kliniken is 1.8 %.

When does M1 Kliniken pay dividends?

M1 Kliniken pays a quarterly dividend. This is distributed in the months of July, August, September, August.

How secure is the dividend of M1 Kliniken?

M1 Kliniken paid dividends every year for the past 0 years.

What is the dividend of M1 Kliniken?

For the upcoming 12 months, dividends amounting to 0.63 EUR are expected. This corresponds to a dividend yield of 3.82 %.

In which sector is M1 Kliniken located?

M1 Kliniken is assigned to the 'Health' sector.

Wann musste ich die Aktien von M1 Kliniken kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of M1 Kliniken from 7/22/2024 amounting to 0.5 EUR, you needed to have the stock in your portfolio before the ex-date on 7/18/2024.

When did M1 Kliniken pay the last dividend?

The last dividend was paid out on 7/22/2024.

What was the dividend of M1 Kliniken in the year 2023?

In the year 2023, M1 Kliniken distributed 0 EUR as dividends.

In which currency does M1 Kliniken pay out the dividend?

The dividends of M1 Kliniken are distributed in EUR.

All fundamentals about M1 Kliniken

Our stock analysis for M1 Kliniken Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of M1 Kliniken Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.